274 related articles for article (PubMed ID: 32328562)
1. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
Chau NG; Ma C; Danga K; Al-Sayegh H; Nardi V; Barrette R; Lathan CS; DuBois SG; Haddad RI; Shapiro GI; Sallan SE; Dhar A; Nelson JJ; French CA
JNCI Cancer Spectr; 2020 Apr; 4(2):pkz094. PubMed ID: 32328562
[TBL] [Abstract][Full Text] [Related]
2. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract][Full Text] [Related]
3. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
4. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
[TBL] [Abstract][Full Text] [Related]
5. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
6. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
7. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract][Full Text] [Related]
9. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract][Full Text] [Related]
10. NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case.
Agaimy A; Tögel L; Stoehr R; Meidenbauer N; Semrau S; Hartmann A; Mantsopoulos K
Virchows Arch; 2021 Dec; 479(6):1095-1099. PubMed ID: 33891143
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
Shah A; Box A; Brenn T; Flaman A
J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
[TBL] [Abstract][Full Text] [Related]
12. CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.
Schaefer IM; Dal Cin P; Landry LM; Fletcher CDM; Hanna GJ; French CA
Genes Chromosomes Cancer; 2018 Sep; 57(9):446-451. PubMed ID: 29700887
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
Chen M; Li S; Jiang L
Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.
Virarkar M; Mallery M; Saleh M; Ramani NS; Morani AC; Bhosale P
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):431-441. PubMed ID: 34297512
[TBL] [Abstract][Full Text] [Related]
15. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.
Giridhar P; Mallick S; Kashyap L; Rath GK
Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):815-821. PubMed ID: 29356890
[TBL] [Abstract][Full Text] [Related]
17. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract][Full Text] [Related]
19. Advances in the pathogenesis and treatment of nut carcinoma: a narrative review.
Wang S; Li J; Tong W; Li H; Feng Q; Teng B
Transl Cancer Res; 2020 Oct; 9(10):6505-6515. PubMed ID: 35117258
[No Abstract] [Full Text] [Related]
20. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]